A Phase II Clinical Trial to Evaluate Safety and Efficacy of XmAb20717 in Advanced Rare Cancers
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
University College, London
Alliance for Clinical Trials in Oncology
University of Leeds
Memorial Sloan Kettering Cancer Center
Massachusetts General Hospital
Translational Research in Oncology
Jules Bordet Institute
Rijnstate Hospital
Massachusetts General Hospital
Jonsson Comprehensive Cancer Center
Abramson Cancer Center at Penn Medicine
Swiss Cancer Institute
Wake Forest University Health Sciences
Stanford University
Case Comprehensive Cancer Center
Memorial Sloan Kettering Cancer Center